Condition
Narcolepsy Type 1 (NT 1)
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Recruiting2
Active Not Recruiting1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07654803Active Not RecruitingPrimary
Radar Sleep Monitoring in Type 1 Narcolepsy: Feasibility
NCT06809803Phase 2RecruitingPrimary
Extended-release Sodium Oxybate in Children
NCT07006233Not ApplicableRecruiting
A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia
NCT04820842Phase 2TerminatedPrimary
A Study of TAK-994 in Adults With Narcolepsy
Showing all 4 trials